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The EAT-Lancet commission recently suggested that transformation to healthy diets by
2050 will require a reduction of at least 50% in consumption of foods such as red
meat and sugar, and a doubling in the global consumption of fruits, vegetables, nuts,
and legumes. A diet rich in plant-based foods and with fewer animal source foods
confers both improved health and environmental benefits. Notably, the risk of vitamin
B12 deficiency increases when consuming a diet low in animal products. Humans
are dependent on animal foods such as dairy products, meat, fish and eggs. Vitamin
B12 deficiency is common worldwide, especially in populations with low consumption
of animal foods because of low socioeconomic status, ethical reasons, or because
of their lifestyle (i.e., vegans). According to the European Food Safety Authoroty, the
recommended adequate intake of vitamin B12 is 4.0 µg/d for adults, and vitamin
B12 requirements are higher during pregnancy and lactation. Infants and children from
deficient mothers and elderly people are at risk for vitamin B12 deficiency. Diagnosis of
vitamin B12 deficiency is hampered by low specificity of available biomarkers, and there is
no consensus yet regarding the optimal definition of low vitamin B12 status. In general, a
combination of at least two biomarkers is recommended. Therefore, this review presents
an overview of vitamin B12 biochemistry and its biomarkers. We further summarize
current recommendations of vitamin B12 intake, and evidence on the associations of
vitamin B12 intake from different nutrient-dense animal foods with vitamin B12 status
markers. Finally, potential consequences of low vitamin B12 status on different health
outcomes for pregnant women, infants and elderly are presented.
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VITAMIN B12
Food Sources of Vitamin B12
Vitamin B12 (cobalamin) is an essential water-soluble
micronutrient of microbial origin (1). It is naturally found
in animal food products, including meat, poultry, (shell)fish,
eggs, milk, and other dairy products (2). Vitamin B12 is generally
not present in plant foods, but fortified breakfast cereals are a
readily available source of vitamin B12 with high bioavailability
(3, 4). Some nutritional yeast products also contain vitamin
B12. This paper will only focus on vitamin B12 intake from
natural food products, e.g. animal foods. According to recent
results of the 2012-2016 Dutch Food Consumption Survey,
the contribution of dairy, meat, (shell) fish, supplements, and
eggs to total vitamin B12 intake is 38.5, 30, 8.5, 8.4, and 4.6%,
respectively1. The nutrient dense animal food products rich
in vitamin B12 are also rich in other nutrients such as zinc,
iron, vitamin D, and proteins. To the best of our knowledge,
interactions of vitamin B12 with these nutrients are not fully
established, and it is not unlikely that associations of low vitamin
B12 with health outcomes may be modified by deficiency of these
nutrients or the presence of disorders that affect the digestive
system. Notably, vitamin B12 and folate act together within the
one-carbon metabolism, and paragraph 4.3.1 will elaborate on a
potential role of high folate and low vitamin B12 status in health.
Uptake of Vitamin B12
Vitamin B12 plays an important role in one-carbon metabolism.
Dietary vitamin B12 is, once ingested, bound to haptocorin (an
animal protein), which carries vitamin B12 to the stomach. In the
stomach, HCl and pepsin are released which release vitamin B12
from animal proteins. Free vitamin B12 then binds to haptocorrin
in the stomach after which it is transported into the intestine,
where vitamin B12 is released by pancreatic enzymes after which
vitamin B12 binds to intrinsic factor (IF) (5). Vitamin B12 -IF
complex binds to the cubulin receptor in the distal ileum, which
takes up vitamin B12 through receptor-mediated endocytosis (5).
Once taken up, vitamin B12 is released to the plasma where
it is bound to its transport proteins; haptocorrin (HC) and
trancobalamin (TC) (6, 7). In the circulation, 20–25% of vitamin
B12 is bound to TC (called holo-TC or active B12), which is taken
up and used by the cells. The other 75–80% of vitamin B12 is
bound to HC, which is stored in the liver (6–8).
Causes of Acquired Vitamin B12 Deficiency
Vitamin B12 deficiency increased with age and is mostly due to
malabsorption of the vitamin. In addition, low intake of animal
food products—as outlined in chapter 3–and use of certain drugs
may also result in vitamin B12 deficiency (Table 1). Absorption
of vitamin B12 is dependent upon several processes including
IF production. If gastric IF production is impaired, like when
gastric parietal cells are destructed in case of gastritis or when
less gastric parietal cells are strongly reduced in case of a gastric
bypass less, this will result in reduced absorption of vitamin
Abbreviations: IF, intrinsic factor; holoTC, holotranscobalamin; MMA,
methylmalonic acid; Hcy, total homocysteine; NTD, neural tube defects.
1https://wateetnederland.nl/resultaten/vitamines-en-mineralen/bronnen
TABLE 1 | Causes of acquired vitamin B12 deficiency.
Cause Effect
MALABSORPTION
Gastric bypass ↓ IF production
Gastrointestinal infection
with H. Pylori
↓ IF production
Ileal resection ↓ Absorption of B12-IF
Bacterial overgrowth ↓ Absorption of B12-IF
Intestinal disease (e.g.,
Crohn)
↓ Absorption of B12-IF
Pernicious anemia Antibodies against IF or parital cells
Difficulties in chewing foods Releasing of B12 from food proteins
NUTRITIONAL
Malnutrition ↓ Vitamin B12 consumption
Vegetarian or vegan diet ↓ Intake of B12 containing animal products
DRUGS
Proton-pump inhibitors Defective release of B12 from food
Metformin ↓ Absorption of B12
Nitrous oxide Inactivation of methionine synthase (in case of NO)
IF, Intrinsic factor; ↓, decreased.
B12. Uptake of vitamin B12 takes place in the distal ileum, and
in case of an ileal dissection, bacterial overgrowth or intestinal
diseases such as Crohn’s disease less vitamin B12 can be taken
up by the ileal cells resulting in lower intake of vitamin B12.
Drugs that regulate secretion of gastric acid production such as
proton-pomp inhibitors can also lead to vitamin B12 deficiency
due to in impaired release of vitamin B12 from food proteins. In
addition, metformin, a drug that is used to lower glucose levels,
has been shown to results in lower vitamin B12 levels in serum
most likely due to interfering with calcium-related binding of IF-
B12 complex to the cubulin receptor (9). Considering drugs the
party drug nitrous oxide has gained a lot of attention recently as
it has been shown that high intake of nitrous oxide can result in
vitamin B12 deficiency due to irreversible oxidation of the cobalt
ion of MeCbl and AdoCbl, which makes both coenzymes inactive
resulting in increased levels of methylmalonic acid (MMA)
and homocysteine (10). Vitamin B12 and active B12 levels are
mostly not low in serum in case of nitrous oxide overabuse and
functional markers such as MMA and homocysteine should be
used for laboratory diagnosis (10).
Biochemistry of Vitamin B12
Different derivatives of cobalamin exist of which
methylcobalamin (MeCbl) and adenosylcobalamin (AdoCbl)
are the physiological co-enzyme forms. MeCbl is a cofactor
in the methionine-synthase dependent remethylation of
homocysteine into methionine, which takes place into the
cytosol. This remethylation reaction is an important step
of the one-carbon metabolism, in which also reduction of
folate derivatives takes place, which are important for DNA
synthesis. In addition, methionine is an essential amino acid
which is involved in formation of the universal methyl donor S-
adenosylmethionine. Low dietary intake of vitamin B12 results in
elevated homocysteine levels andmight affect DNA synthesis and
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DNA methylation. AdoCbl is involved in the l-methylmalonyl-
CoA-mutase-dependent conversion of methylmalonyl-CoA into
succinyl-CoA, which takes place in the mitochondrium (11).
Low dietary intake of vitamin B12 results in accumulation of
methylmalonyl-CoA that converts to MMA. Increasing levels of
MMA are observed in plasma in case of vitamin B12 deficiency.
Biomarkers of Vitamin B12
Several biomarkers (Table 2) exist to evaluate vitamin B12 status
in blood. The most used biomarker is total vitamin B12, which
measures vitamin B12 bound to both transport proteins (HC and
TC), which gives a generally estimation of the vitamin B12 status
in the blood (7, 11). In addition, holoTC (active B12), which is
the transcobalamin-bound vitamin B12 has been suggested to
be an early marker of vitamin B12 status. HoloTC can be used
as an initial test to measure vitamin B12 status in blood (12–
14). Both total vitamin B12 and holoTC are applied in laboratory
diagnostics and functional tests such as homocysteine and MMA
are used to confirm diagnosis in case of low-normal vitamin B12
status. No consensus exists about which cut-off values should be
applied and which is the best marker or combination of markers
to assess vitamin B12 status (15). In general, reference intervals
are used or alternative cut-off values are chose based upon
sensitivity and specificity (14). However, these cut-off values are
not generally applicable, as total vitamin B12 and active vitamin
B12 tests are not harmonized, which hampers interpretation
difficult for general practitioners.
Consideration
Regarding biomarkers of vitamin B12 there is a need to establish
reference intervals of total vitamin B12 in pregnancy as these
levels decrease during pregnancy. In addition, better biomarkers
are necessary to determin vitamin B12 deficiency as total B12 and
active B12 hamper diagnostic specificity.
PRESENT RECOMMENDED DIETARY
INTAKE OF VITAMIN B12 AND THEIR
LIMITATIONS
Dietary Reference Values for Vitamin B12
Several organizations have followed different approaches to set
the dietary reference values for vitamin B12 (Table 3). The
TABLE 2 | Biomarkers of vitamin B12 status in serum or plasma.
Biomarker Indication Interpretation
Total vitamin B12 Global vitamin B12 status ↓ In vitamin B12 deficiency
↑ Myeloid cell proliferation
↓ Pregnancy
Holo-
transcobalamin
Vitamin B12-bound to
transcobalamin or active
B12
↓ In vitamin B12 deficiency
↓ In TC deficiency
Methylmalonic
acid
Functional marker of vitamin
B12 deficiency
↑ Vitamin B12 deficiency
↑ Renal dysfunction
Homocysteine Functional marker of vitamin
B12 deficiency
↑ Vitamin B12 deficiency
↑ Renal dysfunction
↑ Folate deficiency
↓, decreased; ↑, increased.
dietary reference values for adult men and women aged >18
years range between 2 and 4 µg/d depending on the judgments
used. Generally, the increased requirements for vitamin B12 in
women during pregnancy and lactation have been acknowledged
and translated into higher reference values compared with
non-pregnant women. No special intake recommendations
exist for elderly people, despite the evidence that vitamin
B12 malabsorption and deficiency are common in the elderly.
Furthermore, the intake recommendations for infants were
mainly based on outdated observational studies and on vitamin
B12 content in human breastmilk. Measurement of vitamin B12
in breastmilk has been hampered by methodological problems
due to the high milk haptocorrin that interferes with most
available assays. In general, the European Food Safety Authority
(EFSA) panel defined the Adequate Intake of vitamin B12 based
on three indicators of vitamin B12 requirements (16):
1- Maintenance of heamatological markers in patients with
pernicious anemia in a remission phase (i.e., correcting
hemoglobin, mean corpuscular volume, and reticulocyte).
2- Maintenance of the total body stores of vitamin B12 (≈2–
3mg) by adjusting the daily requirements for the daily loss
of the vitamin. The absorption efficacy of vitamin B12 from
foods is assumed to be 40% and the daily loss is between 2
and 6 µg/d (biliary loss or transfer to the fetus or infant (via
the placenta or the breastmilk).
3- Maintenance of normal serum levels of vitamin B12 markers
(total vitamin B12, MMA, holoTC, and Hcy).
Vitamin B12 Intake Necessary for
Maintenance of Normal Vitamin B12
Biomarkers
Approximately 1% of a high oral vitamin B12 dose (i.e., derived
from supplemental cyanocobalamin) crosses the intestinal
barrier into the blood via simple diffusion (17), after saturation of
IF (max. 5 µg/meal is absorbed via IF) (18). Vitamin B12 intake
shows a dose-response relationship with blood vitamin B12
markers. We focused here on studies on vitamin B12 biomarkers
in relation to vitamin B12 intake in the range below 50 µg/d.
Studies using therapeutic doses of vitamin B12 are beyond the
scope of this review.
In a study among 98 Danish post-menopausal women Bor
et al. (19)suggested that an intake of 6 µg/d vitamin B12
(determined from 7-d weighed food records) is sufficient to
maintain highest concentrations of vitamin B12 and holoTC, and
lowest concentrations of MMA and Hcy with median (25–75th
percentiles) of 380 (270–480) pmol/L for vitamin B12, 119 (92–
162) pmol/L for holoTC, 0.12 (0.14–0.17) µmol/L for MMA, and
9.8 (8.3–11.4) µmol/L for Hcy compared to intakes lower than 6
µg/d. A similar study in 299 healthy US adults found that mean
levels of vitamin B12 and holoTC were highest in the intake
range between 4.2 and 7.0 µg/d, while plasma MMA and Hcy
reached lowest levels in subjects who achieved an intake of ≥7.0
µg/d (20).
The association between vitamin B12 markers and intake was
generally weaker in studies in elderly people (21) compared to
those in younger people, in studies considering only dietary
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TABLE 3 | Dietary reference values for vitamin B12 (in µg/d) in different age and sex groups as suggested by different organizations.
EFSA 2015 D-A-CH 2015 NCM 2014 WHO 2004 NL 2003 IOM 1998 SCF 1993 COMA 1991
Infants and children
Age 7Mo−6y 4–12Mo 6–11Mo 7–12Mo 6–11Mo 7–12Mo 6–11Mo 7–12 Mo
Reference value 1.5 µg/d 0.8 µg/d 0.5 µg/d 0.7 µg/d 0.5 µg/d 0.5 µg/d 0.5 µg/d 0.4 µg/d
Age 1–4 y 1–2 y 1–3 y 1–3 y 1–3 y 1–3 y 1–3 y
Reference value 1.0 µg/d 0.6 µg/d 0.9 µg/d 0.7 µg/d 0.9 µg/d 0.7 µg/d 0.5 µg/d
Age 4–7 y 2–5 y 4–6 y 4–8 y 4–8 y 4–6 y 4–6 y
Reference value 4.5 µg/d 0.8 µg/d 1.2 µg/d 1.3 µg/d 1.2 µg/d 0.9 µg/d 0.8 µg/d
Age 7–10 y 7–10 y 6–9 y 7–9 y 9–13 y 9–13 y 7–10 y 7–10 y
Reference value 2.5 µg/d 1.8 µg/d 1.3 µg/d 1.8 µg/d 2.0 µg/d 1.8 µg/d 1.0 µg/d 1.0 µg/d
Age 11–14 y 10–13 y 10–17 y 10–18 y 10–18 y 14–18 y 11–14 y 11–14 y
Reference value 3.5 µg/d 2.0 µg/d 2.0 µg/d 2.4 µg/d 2.8 µg/d 2.4 µg/d 1.3 µg/d 0.2 µg/d
Age 15–17 y 13–19 y 15–17 y 15–18 y
Reference value 4.0 µg/d 3.0 µg/d 1.4 µg/d 1.5 µg/d
Adults (M+F), > 18 y 4.0 µg/d 3.0 µg/d 2.0 µg/d 2.4 µg/d 2.8 µg/d 2.4 µg/d 1.4 µg/d 1.5 µg/d
Pregnant women 4.5 µg/d 3.5 µg/d 2.0 µg/d 2.6 µg/d 3.2 µg/d 2.6 µg/d 1.6 µg/d 1.5 µg/d
Lactating women 5.0 µg/d 4.0 µg/d 2.6 µg/d 2.8 µg/d 3.8 µg/d 2.8 µg/d 1.9 µg/d 2.0 µg/d
EFSA, European Food Safety Authority; NCM, Nordic Council of Ministers; WHO, World Health Organization; NL, Health Council of the Netherlands; IOM, U.S. Institute of Medicine;
SCF, Scientific Committee on Food; COMA, Committee on Medical Aspects of Food Policy.
intake compared to studies on vitamin B12 intake from diet
plus supplements, and in studies considering vitamin B12 intake
up to 100 µg/d than those using larger doses (21). This
could be due to a better absorption of free vitamin B12 from
supplements compared to protein-bound vitamin B12 from
foods. Van Asselt et al., reported a median vitamin B12 intake
(from diet plus supplements) of 6.3 µg/d in elderly Dutch people
(mean age 76 years) with normal vitamin B12 markers (vitamin
B12 >260 pmol/L and MMA<320 nmol/L) (22). Subjects with
mild vitamin B12 deficiency (vitamin B12 <260 pmol/L and
MMA>320 nmol/L) had a median intake of 4.9 µg/d, and
those with a possible deficiency (either low B12 or elevated
MMA) had a median intake of 5.1 µg/d (22). The deficiency
in elderly people could be better explained by malabsorption
disorders instead of by minor variations in intakes (22). In
line with this, associations of plasma concentrations of vitamin
B12, MMA, and Hcy with vitamin B12 intake was not present
in some studies (23, 24) possibly due to age- and disease-
related malabsorption.
A meta-analysis on the association between vitamin B12
intake and biomarkers Dullemeijer et al. estimated that doubling
the intake of vitamin B12 is associated with 11.0% (95% CI:
9.4%, 12.5%) higher serum vitamin B12 concentration (21).
The association between vitamin B12 intake and biomarkers
was stronger in studies conducted in elderly people than in
adult populations, which could be related to low baseline
concentrations of vitamin B12 in the elderly (21). The slope
of the change of plasma vitamin B12 in relation to vitamin
B12 intake flattened when vitamin B12 intake was >100 µg/d
(21), which could reflect the limited proportional absorption of
vitamin B12 from high dose supplements. Compared to plasma
vitamin B12, the changes of serum MMA (mean −7%; 95%
CI = −10 to −4%) in response to doubling vitamin B12 intake
were smaller (21), which could be due to the short observational
time of most studies and to the influence of renal function on
MMA levels.
The increase in plasma vitamin B12 and the decrease
in functional markers appear to depend on population
characteristics (mainly age and accompanying diseases),
duration of the intervention, starting plasma concentrations
of the vitamin, and the administered dose of crystalized
cyanocobalamin, even in non-therapeutic ranges. In general,
a daily intake of free cyanocobalamin as low as 1.5–2.5 µg
provided for approximately 4–6 months may increase plasma
vitamin B12 by 50–100 pmol/L.
Consideration
A total intake of vitamin B12 from the diet between 4 and 7
µg/d is associated with normal plasma vitamin B12 and MMA
and thus appears to be adequate to maintain body vitamin B12
status in adults. This intake might be insufficient if people have
difficulties in chewing foods, releasing the vitamin from its food
binding, and/or absorbing it due to disorders as shown in Table 1
(25, 26). Elderly people with H-pylori infection (26), or food-
cobalamin malabsorption (25, 27, 28) may be at risk for vitamin
B12 deficiency despite sufficient dietary intake. It is unclear if
elderly people would generally benefit from higher vitamin B12
intake recommendations.
THE ASSOCIATION OF ANIMAL FOOD
PRODUCTS CONTAINING VITAMIN B12
WITH CIRCULATING VITAMIN B12
BIOMARKERS FROM OBSERVATIONAL
STUDIES
In addition to supplements or fortified cereals as potential
sources of vitamin B12, this paper focusses on vitamin B12
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intake from natural food products, e.g., animal foods. In total,
19 observational studies were identified addressing associations
of vitamin B12 containing aminal food items with plasma or
serum vitamin B12 biomarkers. These studies were performed
among infants (n = 1 study) (29), children (n = 5 studies) (30–
35), pregnant women (n = 1 study) (36), adults (n = 7 studies)
(3, 19, 20, 37–45), and elderly (n = 5 studies) (22–24, 43, 46–
49). The majority of these studies had a cross-sectional design,
except for some case-control study conducted among infants
(29), children (30), and elderly (24), and a prospective study
(3). The observational studies were heterogenous with respect
to dietary assessment of animal food items or dietary patterns,
usage of different vitamin B12 biomarkers, and statistical
analyses, which hampers the direct comparison between studies
(Table 4). Therefore, this section summarizes main findings from
individual studies by different age categories.
Infants and Children
Two case-control studies among infants (29) and children (30)
investigated the effects of a macrobiotic dietary regime (no
animal foods) on vitamin B12 biomarkers. Plasma vitamin B12
concentrations were significantly lower among macro-biotic fed
infants (n = 47) as compared to their omnivorous fed controls
(n = 56) (29). In another study, adolescents who had received
a macrobiotic diet until 6 y of age and had then switched a diet
containing animal products (n = 73) still had significantly lower
vitamin B12 concentrations and higher concentrations MMA,
but comparable Hcy concentrations, as compared to their age-
matched controls who consumed an omnivorous diet from birth
onwards. These results suggest that switching from amacrobiotic
diet to moderate consumption of animal food products is
inadequate to restore vitamin B12 status among children with a
low vitamin B12 in early childhood (30). A Swedish study among
adolescents [mean (SD) age: 17.5 (1.0) year] compared vitamin
B12 intake between 30 vegans (15 males and 15 females) and 30
sex-, age-, and height-matched omnivores. This study revealed
significant differences in vitamin B12 intake between vegans and
omnivores, with vitamin B12 intakes of 0.0 and 0.1 µg/day for
vegan females and males, respectively, and intakes of 5.0 and 5.9
µg/day for omnivorous females and males, respectively (P for
differences < 0.001)(50).
In contrast to following a well-defined dietary regime, a
Colombian study identified 4 dietary patterns derived from
an 28-item FFQ based on principal component analysis.
Patterns included diets rich in (1) animal protein (e.g.,
beef/pork/veal/lamb, chicken/turkey, milk, cheese), (2) cheaper
protein (e.g., cow tripe/liver, spleen, chicken giblets), (3)
traditional/starch (e.g., rice, potato, plantain), and (4) snacking
products (e.g., candy, ice cream, packed fried snacks, soda,
fruit punch). Only the pattern rich in animal protein was
significantly positively associated with plasma vitamin B12 (P
for trend = 0.003). This study also studied individual animal
food groups, and fully adjusted differences in plasma vitamin
B12 for low vs. high consumers were significant only for meat,
but not for dairy, fish, cows liver, and eggs (32). In line with
these findings, a study conducted in India (n= 512) also showed
statistically significant positive associations of the meat and fish
group with plasma vitamin B12 in fully adjusted models, but
not for other animal products (34). Others observed inverse
associations between vitamin B12 intake from milk with plasma
Hcy, but not for vitamin B12 intake from red meat or cheese (35).
One study measured multiple biomarkers for vitamin B12 status.
Serum MMA and Hcy concentrations were not correlated with
animal food groups, whereas correlation coefficients of serum
vitamin B12 and holoTC with dairy intake were 0.16 (P < 0.05)
and 0.27 (P < 0.01), respectively. In addition, intake of liver pate
correlated with holoTC (r= 0.20, P < 0.05). None of the vitamin
B12 biomarkers were associated with fish or eggs intakes (33).
When considering different animal products within
individual studies among children, differences in vitamin
B12 concentrations were most pronounced when comparing
high vs. low intake of dairy products, followed by meat and fish
intake (32), and dairy products showed stronger correlations
with vitamin B12 and holoTC concentrations compared to liver
pate, meat and fish (33). In another study, only a combined group
of meat and fish was associated with vitamin B12 concentrations,
whereas the individual components fish, chicken, eggs, and dairy
were not related to plasma vitamin B12 (34).
Pregnancy
Only one study among pregnant women (n = 1266) was
identified that addressed the association of vitamin B12 intake
from dairy, meat, (shell)fish, and eggs with circulating levels of
vitamin B12 biomarkers, and presence of vitamin B12 deficiency
in week 34–36 of pregnancy. Results showed that vitamin
B12 from dairy, meat and fish, but not eggs, independently
contributed to plasma concentrations of total vitamin B12,
holoTC and MMA, as shown by statistically significant dose-
response relationships. Vitamin B12 intake from each of these
products groups was also independently associated with a
reduced odds of vitamin B12 deficiency (holoTC<35 pmol/L and
MMA >0.45 µmol/L). Egg-derived vitamin B12 was negatively
associated with holoTC but not associated with other vitamin B12
biomarkers (36).
Adults
Those studies addressing specific animal products revealed that
high dairy consumption was associated with significantly lower
prevalences of vitamin B12 concentrations <185 pmol/L (3, 42)
and 148 pmol/L (3) compared to low dairy consumption(3),
significantly higher vitamin B12 concentrations among highmilk
and cheese consumers compared to low consumers (43), and
significantly lower Hcy concentrations with high dairy intake
compared to low dairy intake (45). Similarly, those with a fish
consumption in the highest quintile had a significantly lower
odds of having vitamin B12 deficiency compared to adults who
had a fish consumption in the lowest quintile (42), and plasma
vitamin B12 concentrations were significantly higher in those
consuming high amounts (fourth quartile) compared to low fish
consumers (first quartile) (43). In contrast, analyses on meat
consumption did not show any relation of meat consumption
with vitamin B12 deficiency (3, 42). Moreover, plasma vitamin
B12 concentrations (43) and serum Hcy (45) did not differ
between high and low meat consumers. Egg consumption was
also not related to plasma vitamin B12 status (42, 43, 45). None
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TABLE 4 | Main characteristics and results of observational studies addressing the relation between dietary intake and vitamin B12 status biomarkers among different age categories.
Author, year,
country, design
Population
(% female)
Age [range]
(years)
Dietary intake Vitamin B12
status biomarker
Results Remarks Final conclusion
INFANTS
Dagnelie et al.
(29), 1989, The
Netherlands,
Case–control
N = 103 10–20
months
Macrobiotic diet
(n = 47),
omnivorous diet
(n = 56)
vitamin B12
(pmol/L)
Geometric mean ± coefficient of variation in:
Marcobiotic group: 149 ± 21.6
Control group: 404 ± 15.6
P for difference < 0.001
None of the macrobiotic fed children had ever
received animal produces or vitamin B12
supplements, except for 10 out of 47 infants
who had received small amounts of dairy
products at some time in their live.
Plasma B12 among
macrobiotic fed infants
significantly lower than
among the control group
CHILDREN
Van Dusseldorp
et al. (30), 1999,
The Netherlands,
Nested
case–control
N = 167
(54%)
macrobiotic
diet (n = 73),
control
(n = 94)
12 [9–15] List of 6 food
groups, including
intake of cheese,
pasteurized milk,
buttermilk and
yogurt.
Vitamin B12
(pmol/L)
MMA (µmol/L)
Hcy (µmol/L)
Correlation coefficients (P-value) of
cobalamin with:
Number of years having followed a macrobiotic
diet: −0.22 (P = 0.06, n = 73)
Frequency of meat consumption: 0.53
(P < 0.0001)
Frequency of chicken consumption: 0.47
(P < 0.0001)
Frequency of dairy consumption: 0.39
(P < 0.0001)
Geometric mean (±1.96SD) concentrations of
Cobalamin in macrobiotic vs. control boys:
213 (107–426) vs. 484 (238–985) pmol/L
Cobalamin in macrobiotic vs. control girls:
288 (112–738) vs. 458 (206–1,020) pmol/L
MMA in macrobiotic vs. control boys:
0.29 (0.09–0.93) vs. 0.15 (0.06–0.43) µmol/L
MMA in macrobiotic vs. control girls:
0.25 (0.09–0.70) vs. 0.17 (0.07–0.40) µmol/L
Hcy in macrobiotic vs. control boys:
8.3 (5.2–13.4) vs. 7.0 (4.2–11.7) µmol/L
Hcy in macrobiotic vs. control girls:
7.6 (3.8–15.1) vs. 7.2 (3.8–13.7) µmol/L
The group of macrobiotic fed children had
received a macrobiotic diet until 6 y of age and
had then switched to a lactovegetarian, lacto
ovovegetarian, or omnivorous diet (macrobiotic
adolescents).
The group of macrobiotic fed children switched
to a diet containing dairy products (200 g milk
or yogurt and 22g cheese/d (supplying on
average 0.95mg cobalamin/d), and fish, meat,
or chicken 2–3 times/wk. In girls, meat
consumption contributed more to vitamin B12
status than the consumption of dairy products,
whereas in boys these food groups were
equally important.
Moderate consumption of
animal products after
cessation of a macrobiotic
diet is insufficient to
restore low vitamin B12
status among adolescents
Villamor et al. (32),
2008, Colombia,
Cross–sectional
N = 972
(49%)
8.7 [5–12] 38 item FFQ
obtained by
mothers to assess
dietary intake
among children
Vitamin B12
(pmol/L)
P for trend across quartiles of plasma B12 with:
Animal protein pattern: 0.003
Cheap protein pattern: 0.75
Traditional/starch pattern: 0.45
Snacking pattern: 0.84
Adjusted differences (95%CI, P for trend) in
B12 concentrations of high vs. low/no
intake of:
Meat: 24 (1 to 48, 0.04)
Dairy: 32 (5 to 95, 0.06)
Fish: 17 (−7 to 41, 0.16)
Cow liver: 5 (−17 to 28, 0.08)
Egg: −25 (−50 to 1, 0.12)
Supplement: 9(−8 to 27, 0.31)
PCA derived patterns:
Animal protein (beef/ pork/veal/lamb,
chicken/turkey, milk, cheese)
Cheaper protein (cow tripe/liver, spleen,
chicken giblets) traditional/starch (rice, potato,
plantain), snacking (candy, ice cream, packed
fried
snacks, soda, fruit punch).
Analyses adjusted for sex, age, frequency of
meat, dairy, fish, cow liver, and
supplement intake.
Strong dose–dependent
positive association
between a pattern
including frequent
consumption of beef,
chicken, and dairy
products and plasma
vitamin B12.
(Continued)
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Hay et al. (33),
2011, Norway,
Cross–sectional
N = 155
(44%)
2 [2–2] 7–day food
records. Diary, liver
pate, meat
(products), fish
(products).
Vitamin B12
(pmol/L) and
holoTC (pmol/L)
Spearman correlations of
Serum Vitamin B12 with: Dairy products: 0.16
(P < 0.05)
Serum HoloTC with: Dairy products: 0.27 (P
< 0.01) Liver pate: 0.20 (P < 0.05)
P for differences of geometric means by
quartiles from food sources: Serum
vitamin B12:
Dairy: P = 0.197
Liver pate: P = 0.212
Meat & meat products: P = 0.986
Fish & fish products: P = 0.865 Serum
holoTC:
Dairy: P = 0.024
Liver pate: P = 0.005
Meat & meat products: P = 0.204
Fish & fish products: P = 0.680
Adjusted for sex and energy intake
MMA and Hcy were not associated with animal
food intake.
In this unfortified toddler
population, vitamin
B12 status was strongest
associated with dairy
intake, and with a lesser
extend to liver pate’
Christian et al.
(34), 2015, India,
Cross–sectional
N = 512
(52.9%)
9.5 [9–10] 136 item Semi
quantitative FFQ,
including amongst
others minced
meat, fish,
chicken, mutton,
meat and fish,
eggs,
non–vegetarian,
curd foods, milk
and dairy
Vitamin B12
(pmol/L)
B (95%CI) T3 vs. T1 of intake with plasma B12:
Minced meat: 0.011 (−0.077 to 0.100)
Fish: 0.052 (−0.031 to 0.134)
Chicken: −0.003 (−0.112 to 0.105)
Mutton: 0.101 (−0.007 to 0.209)
Meat & fish: 0.126 (0.041 to 0.212)
Eggs: −0.031 (−0.122 to 0.061)
Non–vegetarian: 0.124 (0.044 to 0.203)
Curd (yogurt) foods: −0.075 (−0.157 to 0.007)
Milk/dairy: −0.029 (−0.110 to 0.053)
Adjusted for age, sex, BMI, height, SLI score,
maternal education, other food groups in the
table except traditional fermented foods and
raw vegetables, and pregnancy plasma B12
concentrations.
Meat and fish are most
important animal derived
B12 sources among
Indian children
Manioset al. (35),
2017, Greece,
Cross–sectional
N = 600
(51%)
11 [9–13] Three 24 h dietary
recalls (2 week
days, 1 weekend
day)
Hcy (µmol/L) B (p-value) linear regression of Hcy with B12
intake from:
Milk: −0.120 (0.004)
B (p-value) quadratic regression of Hcy with
B12 intake from:
Milk: −0.515 (<0.001)
Adjusted for age, sex, and total vitamin B12
intake from other food sources
Vitamin B12 intake from red meat and cheese
were not associated with Hcy concentrations.
High vitamin B12 intake
from milk was associated
with lower Hcy
concentrations
PREGNANCY
Denissen et al.
(36), 2019, The
Netherlands,
Cross sectional
N = 1,266
(100%)
32.6 ± 3.8 200 item
semi–quantitative
FFQ, including
dairy products (28
items), meat (29
items), (shell)fish (7
items), eggs (1
item)
Vitamin B12
(pmol/L)
holoTC (pmol/L)
MMA (µmol/L)
%difference (95%CI) Q5 vs. Q1:
Dairy–B12: 29 (21 to 37)
Dairy–HoloTC: 53 (41 to 66)
Dairy–MMA: −21 (−27 to −14)
Meat–B12: 15 (8 to 23)
Meat–HoloTC: 20 (10 to 30)
Meat–MMA: −16 (−23 to −9)
Fish–B12: 7 (0.5 to 13)
Fish– HoloTC: 15 (7 to 24)
Fish– MMA: −15 (−21 to −8)
Eggs– B12: 1 (−5 to 7)
Eggs– HoloTC: 9 (1 to 17)
Eggs– MMA: −5 (−12 to 2)
Multivariable adjusted proportional difference in
geometrical means of highest quintile relative to
lowest quintile of intake. Values obtained by
multiple linear regression analyses adjusted for
recruitment group, age, prepregnancy BMI,
education, smoking, vitamin B−12 intake from
supplements, alcohol use, energy intake,
vitamin B−12 intake from mixed dishes, as well
as for vitamin B−12 intake from dairy, meat, fish
and eggs (except for the food group of interest)
(Continued)
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ADULTS (MEAN AGE POPULATION >18 And ≤64 y)
Tuckeret al. (3),
2000,
United states,
Prospective
N = 2,999
(52%)
53.6 [26–83] 126 item Semi
quantitative FFQ.
Vitamin B12 intake
was calculated
from individual
food sources.
Food contributions
to total vitamin
B−12 was
calculated, and
total vitamin B12
intake was divided
into vitamin B12
intake from
supplements,
breakfast cereals,
meat, poultry, fish,
dairy sources, and
all other foods
vitamin B12
(pmol/L)
Prevalence of B12 < 185 vs. 148 pmol/L for:
Dairy upper tertile: 13.4 vs. 6.8
Dairy middle tertile: 21.2 vs. 10.4
Dairy lowest tertile: 24.5 vs. 14.1
P difference T1 and T3<0.001 for both cutoff
levels
Meat upper tertile: 17.4 vs. 8.5
Meat middle tertile: 20.4 vs. 11.4
Meat lowest tertile: 21.5 vs. 11.4
P difference T1 and T3>0.05 for both cutoff
levels
Odds Ratios (95%CI) of having B12 <185 or
<148 pmol/L comparing each dietary pattern
to high supplement intake group:
Meat 57% (n = 740):
2.4 (1.7 to 3.4) or 2.0 (1.2 to 3.3)
Milk 38%,meat 21%, fish 10% (n = 361):
1.6 (1.1 to 2.5) or 1.0 (0.5 to 1.8)
Meat 25%, soups 24%, fish 12%, milk 10%
(n = 592): 2.2 (1.5 to 3.3) or 1.6 (0.9 to 2.6)
Fish 35%, meat 21%, other dairy 10% (n
= 342):
2.1 (1.4 to 3.3) or 1.6 (0.9 to 2.8)
Adjusted for age and sex
Adjusted for age, sex, total energy intake, total
vitamin B12 intake
Dietary patterns were derived from cluster
analysis.
Milk appears to protect
against lower vitamin
B12 concentrations.
Participants in all food
intake groups were
significantly more likely to
have B12
concentrations < 185
pmol/L compared to
subjects in the
supplement group. Only
the meat group differed
significantly from the
supplement group in
having vitamin B12
concentrations< 148 pmol/L.
Gao et al. (38),
2003, China,
Cross–sectional
N = 119
(54%)
42 [35–49] 170 item FFQ from
which intake of
Fruit and milk, Red
meat, and refined
cereals were
composed
vitamin B12
(pmol/L)
Hcy (µmol/L)
OR (95%CI) of having B12 < 221 pmol/L:
Red meat vs. fruit & milk: 2.4 (0.9 to 6.3)
Refined cereals vs. fruit & milk: 6.2 (1.9 to 20.8)
OR (95%CI) of having Hcy>11 for women and
>12 for men:
Red meat vs. fruit & milk: 2.6 (0.9 to 7.4)
Refined cereals vs. fruit & milk: 5.0 (1.5 to 17.5)
Adjusted for age, sex, total energy intake, BMI,
smoking, alcohol use, income and education
level.
The pattern high in fruits
and milk was associated
with a significantly lower
risk of having Hcy >11 or
12 µmol/L and of having
B12 <221 pmol/L
compared to the pattern
of refined cereals. Pattern
of red meat did not differ
in risk of high Hcy or low
B12 compared to the fruit
and milk pattern.
(Continued)
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Koebnick et al.
(40), 2005,
Germany,
Cross–sectional
N = 187
(53%)
46 [25–64] 7 day food records
including 12 food
groups
vitamin B12
(pmol/L) Hcy
(µmol/L)
Median (P25, P75) concentrations according to
type of raw food consumption:
Vitamin B12 concentrations:
Mixed raw food: 175 (142,250)
ovo–lacto–vegetarian: 143 (121,176)
vegan: 126 (88,182) pmol/L Median (P25, P75)
plasma
Hcy concentrations:
Mixed raw food: 14.7 (11.9,18.3)
ovo–lacto–vegetarian: 17.1 (13.1,20.2)
Vegan: 18.5 (13.5,28.9) µmol/L
Unadjusted analyses
Mixed raw food diet included raw meat and fish
Individuals who consumed
a mixed raw food diet had
highest vitamin B12 and
lowest Hcy concentrations
whereas those consuming
a stricht vegan diet had
lowest vitamin B12 and
highest Hcy
concentrations.
Hao et al. (42),
2007, China,
Cross–sectional
N = 2,407
(51%)
49 [35–64] Semi quantitative
FFQ.
Animal–based
foods were
classified in dairy,
egg, animal meat
and fish.
vitamin
B12(pmol/L)
Adjusted OR (95%CI, P for trend) for having
vitamin B12 deficiency (<185 pmol/L):
T3 vs. T1 dairy: 0.5 (0.4 to 0.7, <0.001)
Q5 vs. Q1 egg: 0.8 (0.6 to 1.1, 0.196)
Q5 vs. Q1 meat: 1.0 (0.7 to 1.4, 0.163)
Q5 vs. Q1 fish: 0.4 (0.3 to 0.5, <0.001)
Intake food source divided in tertiles (dairy) or
quintiles (egg, animal meat, fish)
Adjusted for region, area (urban, rural), gender,
age, season
Higher consumption of
dairy and fish was
associated with a lower
likelyhood of having B12
concentrations < 185
pmol/L compared to low
or intermediate
consumption.
Vogiatzoglou et al.
(43), 2009,
Norway,
Cross–sectional
N = 3,067
(55%)
[47–49] 169 item FFQ Vitamin B12
(pmol/L)
Adjusted mean (95%CI) plasma vitamin B12
concentrations in Q4 vs. Q1 B12 intake from:
dairy: 385 (376 to 395) vs. 323 (314 to 332)
milk: 388 (379 to 397) vs. 331 (324 to 338)
Cheese: 370 (362 to 378) vs. 346 (338 to 335)
Meat: 362 (354 to 369) vs. 355 (344 to 366)
(shell) fish: 375 (366 to 385) vs.
339 (331 to 346)
Eggs: 358 (349 to 366) vs. 356 (350 to 363)
P for trend < 0.001, except for meat
(P = 0.189) and eggs (P = 0.837)
Adjusted for sex, energy, use of B vitamin
containing supplements, total intake of other
food groups
Dairy and fish are
significant contributors to
plasma vitamin B12.
Vitamin B12 appears to
be more bioavailable from
dairy products than from
other animal products.
Yakub et al. (44),
2010, Pakistan,
Cross–sectional
N = 872
(59%)
32.4 [18–60] 15 item food
group frequency
questionnaire
composing dietary
patterns
Vitamin B12
(pmol/L) Hcy
(µmol/L)
Adjusted mean plasma vitamin B12
concentrations in Q4 vs. Q1 (P diff) intake from:
Prudent diet: 322 vs. 317 (P diff = 0.85)
High animal protein diet: 335 vs. 312 (P
diff = 0.56)
High plant protein diet: 325 vs. 326 (P
diff = 0.80)
Adjusted mean plasma Hcy in Q4 vs. Q1 (P diff)
intake from:
Prudent diet: 13.97 vs. 15.78 (P diff = 0.26)
High animal protein diet: 18.58 vs. 13.29 (P
diff < 0.001)
High plant protein diet: 12.50 vs. 18.40 (P diff
< 0.001)
Adjusted for age and sex
Patterns identified by factor analyses:
Prudent pattern: high intake of eggs, fish,
uncooked vegetables, juices, and bananas and
other fruits.
High animal–protein pattern: high intake of
meat, chicken, wheat, bananas, and tea with
milk.
High plant–protein pattern: high intake of
cooked vegetables and legumes and a small
intake of meat
Patterns high in animal
and plant proteins were
associated with lower
Hcy, but not with vitamin
B12 concentrations.
Murakami et al.
(45), 2013, Japan,
Cross–sectional
N = 1,050
(100%)
20 [18–22] Diet history
questionnaire
including 17 foods
Hcy (µmol/L) Adjusted geometric mean (95%CI) Hcy
concentrations were significantly lower in Q5
vs. Q1 dairy intake (P for trend 0.02).
Hcy did not differ across quintiles of (shell)fish,
meats, and egg consumption
Adjusted for survey year, region, municipality
level, current smoking, current alcohol drinking,
supplement use, physical activity, BMI, energy
intake, intakes of other foods.
High consumption of dairy
products was associated
with lower Hcy
concentrations
(Continued)
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ELDERLY (MEAN AGE POPULATION >002065 y)
Kwan et al. (46),
2002, Puerto Rica
and Dominicans,
Cross–sectional
N = 603
(58%)
(Hispanic
(n = 449),
non–Hispanic
white (n
= 154))
76.5 [60–93] Semi qualitative
FFQ. Total vitamin
B12 intake divided
into vitamin B12
intake from
supplements,
breakfast cereals,
dairy sources,
eggs, meat,
poultry, fish, and
all other foods
Vitamin B12
(pmol/L)
Proportions of B12 < 185 pmol/L of vitamin
B12 intake from:
Hispanics:
Dairy: 15.8 (T1), 14.2 (T2), 23.6 (T3), P for
diff>0.05
Meat: 15.5 (T1), 15.6 (T2), 22.0 (T3), P
for diff>0.05
Non–Hispanics whites:
Dairy: 9.4 (T1), 10.5 (T2), 20.0 (T3), P for
diff>0.05
Meat: 9.8 (T1), 20.6 (T2), 10.0 (T3), P
for diff>0.05
Adjusted for age, sex, and energy intake. Dairy and meat
consumption are not
significantly related to
vitamin B12 status
Lasheras et al.
(47), 2003, Spain,
Cross–sectional
N = 140
(58%)
Men: 73.3
women: 74.2
[60–80]
FFQ for dietary
intake, individual
foods vegetables,
legumes, fruit,
cereals, potatoes,
fish, meat, eggs,
milk and dairy,
other foods.
Hcy (µmol/L) Multiple linear regression with beta (95%CI) for
Hcy and intake of:
Meat: −0.083 (−0.035 to 0.010)
Milk and dairy products: 0.004 (−0.020 to
0.021)
Total dietary score: −0.156 (−0.545 to −0.015)
Adjusted for sex, age, and serum creatinine
Total diet score based on quartiles of the
intakes (grams per day) of main food groups
contributing to intake of B–vitamins: i.e., meat,
fish, milk, dairy, fruit, and vegetables.
Only the dietary pattern
characterized by high
intakes of B vitamin–rich
foods was associated with
lower Hcy concentrations
and lower proportion of
high Hcy.
Ledikwe et al. (48),
2004,
United states,
Cross–sectional
N = 179
(55%)
76.5 [66–80] 24 h recall, 2
months interval
during 10 months,
categorized 6
main food
sources; High
nutrient dense;
vegetables, fruit,
milk, poultry fish.
Low nutrient
dense;
dairy
desserts, meat
Vitamin B12
(pg/mL)
Least Square Mean (95%CI) vitamin
B12 (pg/mL):
Low–nutrient dense pattern: 455 (406–504)
High–nutrient dense pattern: 556 (493–618)
P for difference 0.03
Least Square Mean (95%CI) Hcy (µmol/L):
Low–nutrient dense pattern: 9.9 (9.1–10.7)
High–nutrient dense pattern: 9.9 (8.9–10.8)
P for difference 0.981
OR (95%CI) of having B12<350 pg/mL while
consuming low nutrient dense pattern group
compared to high nutrient dense pattern:
2.15 (0.93–4.96)
Significance tests adjusted for energy intake,
age, sex, tobacco use, alcohol use
Low–nutrient–dense pattern: higher intake of
breads, sweet breads/desserts, dairy desserts,
processed meats, eggs, and fats/oils
High–nutrient– dense pattern: higher intake of
cereals, dark green/yellow vegetables, other
vegetables, citrus/ melons/berries, fruit juices,
other fruits, milks, poultry, fish, and beans
Consumption of a
high–nutrient–dense
dietary pattern was
associated with higher
vitamin B12
concentrations compared
to a low nutrient dense
dietary pattern. Hcy
concentrations did not
differ between high and
low nutrient dense diets.
Vogiatzoglou et al.
(43), 2009,
Norway,
Cross–sectional
N = 2,861 [71–74] 169 item FFQ Vitamin B12
(pmol/L)
Adjusted mean (95%CI) plasma vitamin B12
concentrations in Q4 vs. Q1 B12 intake from:
Dairy: 358 (348,368) vs. 318 (309, 328)
Milk: 357 (347,367) vs. 317 (307, 327)
Cheese: 343 (332,355) vs. 337 (328, 347)
meat & meat products: 342 (332, 354) vs. 340
(332, 349)
Fish and shellfish: 359 (350, 369) vs. 321 (311,
330) eggs: 334 (324, 344) vs. 339 (331,347)
P for trend < 0.01, except for cheese
(P = 0.707), meat (P = 0.522), and eggs
(P = 0.677)
Adjusted for sex, energy, use of B vitamin
containing supplements, total intake of other
food groups
Dairy and fish are
significant contributors to
plasma vitamin B12.
Vitamin B12 appears to
be more bioavailable from
dairy products than from
other animal products.
(Continued)
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of the studies investigated the link between animal food products
with MMA or holoTC concentrations in adults.
A number of studies described vitamin B12 intake or vitamin
B12 biomarkers among omnivores, vegetarians and vegans. All
studies consistently observed that vitamin intake was lowest,
intermediate and highest among vegans, vegetarians and meat-
eaters, respectively (51–55). Similarly, studies also observed
lowest, intermediate and highest vitamin B12 concentrations
among vegans, vegetarians and meat-eaters, respectively (51,
54–56), or with holoTC concentrations(51). In line with this,
prevalences of vitamin B12 deficiency were highest among
vegans and lowest among omnivorous (52, 54, 56), although
it should be noted that these studies used different criteria
to define vitamin B12 deficiency. Other studies addressing
dietary patterns in relation to vitamin B12 status have used
different approaches to define patterns. Tucker et al derived
patterns by cluster analysis. Food groups that contributed to
vitamin B12 were entered into the analysis as percentages
of total individual vitamin B12 intake. The cluster procedure
assigns individuals to predetermined numbers of clusters in a
manner that maximizes the difference across groups for the
included variables. Factor analyses reveal that 6 patterns led
to the clearest separation of vitamin B12 sources, being (1)
supplements (61% Supplements, 11% meat), (2) meat (57%
meat), (3) milk (38% milk, 21% meat, 10% fish), (4) cereal (37%
Cereal, 17% meat, 12% milk, (5) meat and soups (25% Meat,
24% soups, 12% fish, 10% milk), and (6) fish (35% Fish, 21%
meat, 10% other dairy). Plasma vitamin B12 concentrations were
significantly lower in the meat pattern than in the cereal and milk
patterns, despite similar average vitamin B12 intakes in these
3 groups. Subjects in all food intake groups were significantly
more likely to have plasma vitamin B-12 concentrations <185
pmol/L compared to subjects in the supplement group, with
odds ratios ranging from 1.6 for the milk group to 2.4 for
the meat group. For the likelihood of plasma vitamin B-12
concentrations <148 pmol/L, the meat group was the only
group that differed significantly from the supplement group
[OR (95%CI) = 2.0 (1.2–3.3)] (3). Another study also used
factor analyses to identify major dietary patterns. Three patterns
were defined as (1) prudent diet (high intake of eggs, fish,
uncooked vegetables, juices, bananas, and other fruits), (2)
high animal-protein diet (high intake of meat, chicken, wheat,
bananas, and tea with milk), and (3) high plant-protein diet
(large intake of cooked vegetables and legumes and a small
intake of meat). High intakes of the prudent dietary pattern
and the plant protein dietary pattern (quartile 4) compared
with lowest intake (quartile 1) were associated with a reduced
odds of hyperhomocysteinemia (Hcy > 15 µmol/L), with OR
(95% CI) of 0.52 (0.30–0.90) and 0.42 (0.25–0.69), respectively.
In contrast, a high consumption of the animal-protein diet
was positively associated with hyperhomocysteinemia [OR (95%
CI) quartile 4 vs. quartile 1= 2.10 (1.22–3.60). Vitamin B12
concentrations did not differ across quartiles of any of the diets
(44). Finally, another study investigated if vitamin B12 and Hcy
concentrations differed across different degrees of vegetariarism
(vegan, ovo-lacto-vegetarian, and mixed raw food diet including
raw meat and fish). This study revealed that consumption of
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a vegan diet had lowest median vitamin B12 concentrations
and highest Hcy concentrations and consumption of a pattern
with mixed raw foods had highest vitamin B12 and lowest Hcy
concentrations (40).
Elderly
Five observational studies were identified among elderly (average
age population>65 y), out of which 4 focussed on specific animal
products (43, 46, 47, 49) and two on dietary patterns (47, 48).
A study investigating vitamin B12 intake from supplements,
breakfast cereals, dairy and meat consumption revealed that only
cereal, but not dairy or meat consumption was related to vitamin
B12 concentrations and proportions of B12 concentrations <185
pmol/L. In line with this, meat and milk and dairy products
were not associated with Hcy concentrations (47). However,
other studies showed that high consumption of dairy and fish
were accompanied by higher plasma vitamin B12 concentrations
compared to low consumption of these food groups(43), and
that high intakes (T3 vs. T1) of meat, (shell)fish, and dairy
were associated with an increased odds of having vitamin B12
concentrations >200 pmol/L (49).
A dietary pattern characterized by high intakes of foods
rich in B-vitamins, such as meat, fish, milk, dairy, fruit, and
vegetables, was associated with lower mean Hcy concentrations
(47). Another study comparing consumption of high vs. low
nutrient-dense dietary pattern revealed higher vitamin B12
concentrations in those consuming a high nutrient dense pattern
compared to those consuming a low nutrient dense dietary
pattern. Hcy concentrations did not differ between these the high
and low nutrient dense patterns. In this study, a high nutrient-
dense pattern was defined as higher intake of cereals, dark
green/yellow vegetables, other vegetables, citrus/ melons/berries,
fruit juices, other fruits, milks, poultry, fish, and beans, whereas a
low-nutrient-dense pattern consisted of higher intake of breads,
sweet breads/desserts, dairy desserts, processed meats, eggs, and
fats/oils (48).
Summary of General Findings and
Considerations
Dairy consumption seems to be the strongest determinant of
vitamin B12 concentrations. However, when comparing the
magnitude of the relation of dairy, meat, fish or egg consumption
with vitamin B12 status it is essential to adjust statistical analyses
for vitamin B12 intake from other animal food products, which
was done in 5 studies (3, 34, 35, 43, 49). In addition, the
specific individual food items representing dairy, meat, and fish
consumption could not always be derived from the individual
studies, which hampers direct comparison between studies.
Finally, nutrient-density of different dairy (milk, yogurt, cheese,
curd cheese), meat (chicken, pork, veal), and fish (lean vs. fatty)
differs considerably. There is a knowledge gap regarding the
bioavailability of vitamin B12 from these different animal food
products. In addition, associations of different animal product
groups with MMA and holoTC remain largely unknown.
VITAMIN B12 INTAKE OR STATUS AND
HEALTH OUTCOMES
This section addresses the associations between low vitamin
B12 intake or status (defined by abnormal biomarkers) and
several health outcomes from epidemiological studies performed
in vulnerable population groups.
Maternal Vitamin B12 Status and
Pregnancy
Vitamin B12 deficiency can cause megaloblastic
anemia/pernicious anemia (57). Women with untreated
pernicious anemia have often infertility problems or repeated
abortions. When women were diagnosed with vitamin
B12 deficiency and had received vitamin B12, pregnancy
occurred (58–60).
The metabolisms of vitamin B12 and folate interact.
Supplementation of folic acid before pregnancy and in the first
pregnancy trimester reduces the risk of neural tube defects
(NTDs) in the child. An inverse association has been reported
between NTDs risk and vitamin B12 status or polymorphisms
in vitamin B12 metabolizing enzymes (61–64). Ray et al. have
shown that a low serum holotranscobalamin (<55.3 pmol/L) at
15–22 weeks of gestation was associated with the risk of NTDs
in a study that was done in Ontario after the fortification with
folic acid (65). There is a general agreement that vitamin B12
concentrations >250 pmol/L in women entering pregnancy is
associated with low risk for NTDs compared to when vitamin
B12 is below this level (63). These findings may suggest that
supplementation with vitamin B12 may reduce the risk for NTD.
However, it is unknown if supplementation with both folic acid
and vitamin B12 decreases the number of births with a NTD
compared to supplementation with folic acid alone.
Maternal vitamin B12 status determines vitamin B12 status
of the child at birth and thereafter. Vitamin B12 in neonates
at birth is higher than that in plasma of the mother, but it
generally declines in the infants after birth. In a nested case-
control study, concentrations of vitamin B12, Hcy, and MMA
were assessed in healthy pregnant women (n = 114) from week
18 of pregnancy through 6 mo postpartum and related to infant
cobalamin status at 6 mo, and compared with healthy, never-
pregnant women aged 18–40 y controls (n = 123). Compared
to controls, vitamin B12, Hcy and MMA were lower in pregnant
women at 18w of pregnancy. Vitamin B12 significantly decreased
from week 18 to week 36 of pregnancy and increased again
by 6 wk postpartum, whereas Hcy and MMA concentrations
increased from week 18 of pregnancy to 6 wk postpartum.
Infant vitamin B12 concentration at 6 months correlated with
maternal vitamin B12 concentration during pregnancy and
postpartum (rho = 0.36–0.55, P < 0.001). A maternal vitamin
B12 concentration <394 pmol/L during week 18 of pregnancy
was associated with an increased risk (OR: 4.2; 95% CI: 1.5,
11.5) of infant vitamin B12 deficiency at 6 mo (defined as tHcy
≥6.5 µmol/L) (66). Breastfed infants are at risk for deficiency
in this period if their depleted mothers are not taking vitamin
B12-containing supplements (67). Most cases of infantile vitamin
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B12 deficiency become manifested between 6 and 11 months of
age. Neuromuscular and growth or developmental disorders or
cerebral atrophy can occur. Symptoms such as irritation, feeding
difficulties, stunting, or anemia have been reported in deficient
neonates. Vitamin B12 deficiency may leave residual neurological
abnormalities (68).
Breastfeeding
Prolonged breastfeeding is related to food insecurity and
represent a problem in many parts of the world where the
mothers have multiple micronutrient deficiencies. In Indian
children (mean age 16 months) from families of low to middle
socioeconomic status, prolonged breastfeeding was associated
with stunting, anemia, low weight, or wasting (low weight-
for-length) in the child (69, 70). A causal role for vitamin
B12 deficiency in childhood stunting is possible, but not well-
investigated due to possible confounding by intestinal infections,
protein deficient diet or multiple nutrient deficiencies that
can affect stunting (71–73). Maternal and/or infant vitamin
B12 status has been related to infant physical growth (74),
anemia, and cognitive and mental function (75). However,
it is unknown if requirements for vitamin B12 in pregnant
and lactating women should be increased, and if improving
maternal or child vitamin B12 status can improve the
outcome such as anemia (76) and cognitive development in
the child. There are currently some studies ongoing on this
topic (77).
Elderly
Several epidemiological studies reported associations between
vitamin B12 biomarkers and brain health, cognitive function,
or bone health [reviewed in (78)]. In addition, some evidence
appears to suggest that lower B12 status is related to increased
pro-oxidant and decreased antioxidant status (79). In a 5-y follow
up study among dementia-free elderly people, vitamin B12 in
the lowest tertile (<308 pmol/L) or holoTC (< 54 pmol/L)
was negatively associations with accelerated brain volume loss,
compared with those with higher levels (80). No such association
was observed for MMA and Hcy with brain volume loss. In
contrast, Smith et al., observed an association between high
plasma Hcy and MMA and the risk of cognitive impairment
in elderly people who were free of dementia at baseline, while
higher holoTC and vitamin B12 showed a negative association
with the risk of cognitive impairment (81). Most intervention
studies to lower tHy have used multivitamins containing folic
acid and vitamin B12 among other vitamins, and studies have
shown a protective effect of multivitamins containing vitamin
B12 on global cognition (82), brain shrinkage (83), or quality of
life scores (84).
In a 6-y follow up study in Swedish elderly men (n =
790; age range 70–81 years), lowered holoTC was associated
with an increased risk of fracture (hazard risk for the lowest
tertile of holoTC= 1.74; 95% CI 1.12–2.69) (85), while Hcy and
MMA were not associated with bone mineral density or fracture
risk. In a nationally representative cross-sectional study in U.S.
women ≥50 years, Baily et al., have reported an association
between elevated Hcy and MMA and the risk of lumbar spine
osteoporosis, but B12 and MMA were not associated with bone
mineral density (86). In an update meta-analysis including RCTs
on the association between homocysteine-lowering trials and
fracture risk in elderly people (87)., Garcia Lopez et al., found no
association between lowering Hcy (using folic acid and vitamin
B12) and the risk of fractures (87).
In general, the evidence from homocysteine-lowering trails by
B-vitamins on cognition or bone fracture is mixed and there are
several negative studies (78). There is some evidence that vitamin
B12 supplementation could have positive effects on health in
elderly people who are vitamin B12-deficient. Nevertheless, more
research in this group of elderly people is still warranted.
Special Considerations
The Health Significance of High Folate and Low
Vitamin B12
There is some concern about supplementing high doses of folic
acid to women of reproductive age with low vitamin B12 intake.
Supplementing folic acid >1 mg/d is common in many parts
of the world where low vitamin B12 is endemic, thus causing
unbalanced intake and status of the two B-vitamins. Vitamin
B12 deficiency is common in pregnant women from many
countries such as Colombia (88), Brazil (89), or India (90). Using
multivitamin supplements before pregnancy is not common and
is related to education and income level (91). Imbalanced levels of
folate and vitamin B12 (i.e., high folate and low B12) have raised
some concern, although this topic is not well-investigated yet.
Due to low animal source foods, Indian women are a good
example of a population with imbalanced folate-to-B12 ratio. A
small observational study including Indian women at 36 weeks
of gestation and their newborn children within 24 h after birth
reported a negative association between folate-to-B12 ratio and
birth weight, birth length, and head and chest circumferences
(92). It has been reported that neonates born to Indian women
with low B12 intake, consuming >1 mg/d of folic acid, and
those with a low B12-to-total folate intake ratio are at increased
risk of being born small for gestational age (93). Moreover, high
red blood cell (RBC)-folate in Indian pregnant women has been
related to adiposity in their children (94) and to increased risk of
insulin resistance in the children if maternal plasma B12 was also
low (94, 95). The risk of gestational diabetes was higher in vitamin
B12-deficient Indian women (95), and the risk of persistent
diabetes in the deficient women with gestational diabetes was
higher in those women with higher folate status (95).
In UK pregnant women, both folate and vitamin B12 status
showed inverse associations with maternal BMI (96). Vitamin
B12 insufficiency was also associated with insulin resistance in
those women (96). Women with a combination of low plasma
vitamin B12 (<170 pmol/L) and folate (<10.3 nmol/L) had
the highest BMI, while those with high vitamin B12 (>238
pmol/L) and folate status (>18.3 nmol/L) had the lowest BMI
(96). Another study in UK pregnant women (beginning of
the 3rd trimester) observed a negative association between
maternal vitamin B12 and the risk of obesity and gestational
diabetes (97). In pregnant women with gestational diabetes,
the risk for fetal macrosomia was higher in the highest folate
quartile and lowest vitamin B12 quartile (97). In a study among
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Spanish women, maternal folate was negatively associated with
insulin sensitivity (HOMA-IR test), while low vitamin B12
was associated with insulin resistance (98). Given these close
interactions between vitamin B12 and folate, it is not unlikely
that other nutrient-nutrient interactions occur, for example with
n-3 fatty acids. As such, future studies may also take nutrient-
density of specific animal food products or dietary patterns
into account.
The Health Significance of High Vitamin B12 Intake
and Status
High dietary intake of vitamin B12 has not been shown
to be disadvantageous. Supplemental forms of vitamin B12
are considered safe and there is no evidence-based Tolerable
Upper Intake Level for vitamin B12. However, elevated plasma
concentrations of vitamin B12 (often defined as plasma vitamin
B12 levels >600, >800, or >1,000 pmol/L) in individuals not
receiving supplemental vitamin B12 have been described in
studies in patients with different cancers, liver diseases, or type 2
diabetes (99) that were later attributed to renal dysfunction (100,
101). The clearance of a single dose of radiolabeled vitamin B12
has been shown to be delayed in patients with renal dysfunction
(101). Studies conducted in hospital settings have shown
that elevated plasma vitamin B12 is associated with elevated
plasma levels of liver enzymes and creatinine or albuminurea
(102) and several clinical conditions such as chronic kidney
disease, diabetes, liver disorders (of any etiology), alcoholism, or
malignancies (100, 103, 104).
Elevated plasma vitamin B12 has been shown to predict
future cancer (105), cardiovascular mortality in cohort studies
(106), and levels above 400 pmol/L may predict short term
mortality (within 90 days) irrespective of the cause of death in
hospitalized elderly patients (107). A prospective study on 161
patients with different cancers investigated serum vitamin B12
concentrations and the time of death (108). The global median
survival time was 45 days (CI 95%: 32–56 days). The highest
mortality corresponded to the highest vitamin B12 levels. A
significant link was found between elevated vitamin B12 (>600
pmol/l) and the presence of metastasis, a tumor or liver problems
(108). In a recent study based on primary care database, the
incidence rate ratio for cancer was 4.72 (95% confidence interval:
3.99–5.58) in persons with vitamin B12>1,000 pmol/L compared
to those with a low vitamin B12 levels after multivariate
adjustments (109).
Notably, a causal role for vitamin B12 in future diseases or
mortality cannot be assumed based on the presence of elevated
plasma vitamin B12 levels. High vitamin B12 test results could
be due to supplementation (i.e., long storage time), release from
damaged tissues, or reduced kidney excretion. In all instances
high plasma vitamin B12 levels are likely to be too unspecific to
be used as a screening test for existing tumors or to predict future
health outcomes. The likelihood of detecting cancer in patients
with high vitamin B12 test has not been studied. Considering the
high rate of false positive results (with seriously negative impact
on patients), there is currently no evidence to initiation of further
cancer diagnostic tests in subjects with plasma vitamin B12 levels
>600 pmol/L.
Consideration
Studies reporting on the relationship between vitamin
B12 intake and health outcomes have limitations due to
methodological variations related to quantifying the intake,
differences in population characteristics and to the fact that
clinical outcomes such as anemia or neuropathy are late
manifestations of the deficiency and are not specific for vitamin
B12 deficiency.
OVERALL SUMMARY
The current recommendation is to decrease consumption
of animal foods and increase consumption of plant foods,
as recently suggested by the EAT-Lancet commission (110).
However, a major concern of diets low or without animal
products is the risk of vitamin B12 deficiency. This review showed
that a total intake of vitamin B12 from the diet between 4 and 7
µg/d is associated with normal plasma vitamin B12 and MMA
and thus appears to be adequate to maintain body vitamin B12
status in adults. However, this intake might not be sufficient if
people have difficulties in chewing foods, releasing the vitamin
from its food binding, and/or absorbing it due to intrinsic factor
antibodies or medications (25, 26). It is currently unknown if
vitamin B12 requirements should be age-specific, since vitamin
B12 deficiency is common in elderly.
When considering specific animal food products, dairy
consumption seemed to be a stronger determinant of vitamin
B12 concentrations than meat, fish and eggs. However,
nutritional composition of different dairy (milk, yogurt, cheese,
curd cheese), meat (chicken, pork, veal), and fish (lean
vs. fatty) differs considerably, and bioavailability of vitamin
B12 from these different animal food products together
with potential interactions between vitamin B12 and other
nutrients from these nutrient-dense animal products are unclear.
Therefore, nutrient-density or well-known interactions between
nutrients, such as folate and vitamin B12, should also be
considered when studying the relations of intake on status
or health.
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